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Chitosan and cloxacillin 
combination improve antibiotic 
efficacy against different lifestyle of 
coagulase-negative Staphylococcus 
isolates from chronic bovine 
mastitis
María L. Breser1,2, Verónica Felipe2, Luciana P. Bohl1,2, María S. Orellano1, Paula Isaac1,2, 
 Agustín Conesa1,2, Virginia E. Rivero3, Silvia G. Correa3, Ismael D. Bianco4 & Carina Porporatto  1,2
Bovine mastitis affects the health of dairy cows and the profitability of herds worldwide. Coagulase-
negative staphylococci (CNS) are the most frequently isolated pathogens in bovine intramammary 
infection. Based on the wide range of antimicrobial, mucoadhesive and immunostimulant properties 
demonstrated by chitosan, we have evaluated therapy efficiency of chitosan incorporation to cloxacillin 
antibiotic as well as its effect against different bacterial lifestyles of seven CNS isolates from chronic 
intramammary infections. The therapeutic effects of combinations were evaluated on planktonic 
cultures, bacterial biofilms and intracellular growth in mammary epithelial cells. We found that biofilms 
and intracellular growth forms offered a strong protection against antibiotic therapy. On the other 
hand, we found that chitosan addition to cloxacillin efficiently reduced the antibiotic concentration 
necessary for bacterial killing in different lifestyle. Remarkably, the combined treatment was not only 
able to inhibit bacterial biofilm establishment and increase preformed biofilm eradication, but it also 
reduced intracellular bacterial viability while it increased IL-6 secretion by infected epithelial cells. These 
findings provide a new approach to prophylactic drying therapy that could help to improve conventional 
antimicrobial treatment against different forms of bacterial growth in an efficient, safer and greener 
manner reducing multiresistant bacteria generation and spread.
Mastitis is the most prevalent and costly disease in dairy cattle around the world1,2. Although its incidence varies 
according to the country and the type of herd management, the economic losses caused by this pathology include 
costs above 10% of net income of dairy farms1,3. Coagulase-negative staphylococci (CNS) previously considered a 
minor or opportunistic pathogens, are currently the most predominant isolated bacteria in intramammary bovine 
mastitis in dairy cattle worldwide4–7. Remarkably, CNS have been associated with persistent infections and high 
resistance to antibiotic therapy8–12. These may be because CNS have higher mutation rate and permeability to the 
horizontal transference of virulence factors than other mastitis-associated pathogens13–15. Some authors suggest 
that CNS could act as a reservoir or transport of large variability of virulence factors into mastitis pathogens13,16,17. 
In view of the above facts, it is clear that a more effective therapy to CNS infections control seems necessary.
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Bacterial growth in biofilms or at the intracellular levelly represents important virulence factors that may be 
associated with the persistence of intramammary infections18–20. Some authors have suggested that CNS biofilm 
may offer protection against different antimicrobial strategies to develop recurrent infections under physiological, 
metabolic and/or immunological stress environments18–22. Other suggest that bacterial intracellular maintenance 
on host cells is an important strategy that allows hiding as well as avoiding the recognition of host defense and 
antimicrobial therapies20.
Even when antibiotic therapy is the most efficient treatment to mastitis control, in many cases, infections can-
not be fully resolved, generating bacterial resistance and presence of antibiotic residues in milk23. On the other 
hand, antibiotic prophylaxis during the drying period has had the highest cure rate of subclinical and chronic 
infections and has prevented the development of new intramammary infections during the dry and the peripar-
tum period24,25. Nowadays, the most frequently used drying therapies for dairy cattle are cloxacillin, ampicillin 
and ceftiofur26,27. Prolonged antibiotic use increases selective pressure on bacterial populations and predisposes 
the microorganism to develop resistance28,29. However, cloxacillin resistance rates and efficacy against different 
bacterial growth mode isolated from mastitis have not been fully clarified. The high rate of bacterial resistance to 
traditional antimicrobials and the lack of development of new antibiotics by the pharmaceutical industry present 
a great problem not only in the veterinary field, but also in public health worldwide28,29. Based on the emergence 
of high antibiotic resistance in bovine isolates, it is necessary to incorporate innovative strategies to intramam-
mary control and to prevent the development of multiresistant strains.
Chitosan is a natural cationic polymer with antimicrobial activity against a broad spectrum of pathogens30,31. 
Chitosan is biodegradable, biocompatible, bioadhesive, bioactive and non-toxic, and has been proposed to dif-
ferent therapeutic applications in a wide range of administration routes30,31. Antimicrobial activity of this biopol-
ymer is based on its physical properties, and therefore it is more difficult to develop or transfer resistance31. 
Currently, the World Health Organization recommends the development of new therapies that minimize the 
use of antibiotics in food producing animals in order to prevent the generation and the spread of multiresistant 
bacteria.
Based on this, some countries have started to prohibit antibiotic uses as growth promoters and prophylactic 
treatment32,33. In the present study, we analyzed seven isolates from chronic bovine mastitis, which were identified 
as CNS and were refractory to different antibiotic therapies. All of them were able to grow in bacterial biofilms 
and intracellular form in a bovine mammary epithelial cell line. Our results show that chitosan addition to clox-
acillin therapy significantly reduced antibiotic concentration to improve bacterial killing against planktonic cul-
tures, preformed biofilms and intracellular growth, compared to conventional antibiotic treatment. These findings 
may contribute to understand the influence of different bacterial lifestyle and antibiotic resistance and provide 
bases for new strategies to be applied during the drying period to control persistent intramammary infections and 
prevent the development and spread of multiresistant bacteria.
Results
Antibiotic susceptibility of CNS isolates from chronic bovine mastitis. Isolates from chronic masti-
tis were tested for their susceptibility to different antibiotics frequently used in the veterinary clinic. In our study, 
penicillin, erythromycin, rifampicin, ampicillin, lincomycin and cefoxitin were tested5. Cefoxitin was used as 
an indicator of methicillin resistance34. Antibiogram tests showed that CNS isolates from chronic bovine mas-
titis (CM-CNS) exhibited 85%, 57% and 42% resistance to penicillin, ampicillin and methicillin, respectively 
(Table 1). On the other hand, 71%, 57% and 14% of chronic isolates showed resistance to erythromycin, linco-
mycin and rifampicin, respectively (Table 1). Notably, 85%, 71% and 57% of these isolations showed resistance 
to more than two, three and four antibiotics with different mechanisms of action (Table 1). Nevertheless, isolates 
from chronic mastitis presented different antibiotic resistance-patterns: six out of seven chronic isolates showed 
antibiotic multiresistance, although one of them that was susceptible to all of the antibiotics tested (Table 1). 
Based on susceptibility criteria by conventional antibiograms it was not possible to discriminate a clear pattern 
of multiresistance.
Cloxacillin effect on planktonic cultures and preformed bacterial biofilms of CNS isolates 
from chronic bovine mastitis. As far as we know, the dry-period prophylaxis treatment shows the major 
cure-rate for chronic infections. On this basis, we analyzed cloxacillin susceptibility of our chronic isolates. Taking 
Isolates AMP PEN FOX ERY RIF LIN
CM-CNS1 S R R S S R
CM-CNS2 R R S R S R
CM-CNS3 R R R R S R
CM-CNS4 R R R R S S
CM-CNS5 S R S R S S
CM-CNS6 R R S R R R
CM-CNS7 S S S S S S
Resistant (%) 57 85 42 71 14 57
Table 1. Antibiotic susceptibility in CNS isolates from chronic bovine mastitis. R, resistant; S, susceptible. AMP, 
ampicillin; PEN, penicillin G; FOX, cefoxitin; ERY, erythromycin; RYF, rifampicin; LIN, lincomycin. Percentage 
of resistance to each antibiotic is shown in the last row.
www.nature.com/scientificreports/
3SCIENTIFIC RepORts |  (2018) 8:5081  | DOI:10.1038/s41598-018-23521-0
into account β-lactamase CLSI-breakpoints for CNS to Minimal Inhibitory Concentration (MIC)34, six of seven 
isolates were cloxacillin-resistant, while CM-CNS7 isolate was cloxacillin-susceptible (Table 2). In our work, all 
isolates from chronic mastitis grew up in biofilm forms on abiotic surfaces (Supplementary Fig. 1). In order to 
understand if biofilm influence the cloxacillin resistance, we evaluated the Minimal Bactericidal Concentration 
(MBC) required against planktonic cultures (P-MBC) and preformed biofilms (B-MBC). We found that the clox-
acillin concentration required to kill bacterial cells inside biofilms was higher than the amount needed for plank-
tonic cultures. In fact, bacteria growing inside the biomass of biofilms needed between 16- to 128-fold higher 
cloxacillin concentration than the same bacteria growing in planktonic lifestyle, even with a susceptible isolate 
(Table 2). Strikingly, when grown inside biofilms, the CM-CNS7 isolate, which was sensitive to all antibiotics 
tested including cloxacillin, did not show any difference from others multiresistant CNS isolates (Table 2). On the 
contrary, in the biofilms form the CM-CNS7 isolate needs higher concentrations of antibiotic than other chronic 
isolates. Together, our data suggest that the growth of bacteria within biofilms mass could be determinant in the 
failure of antibiotic therapies, even in susceptible bacteria (defined by conventional methods). This suggests that 
this type of growth mode cannot be ignored in bacterial susceptibility tests.
Chitosan antimicrobial activity on planktonic cultures and preformed biofilms of CNS isolates 
from chronic bovine mastitis. Cloxacillin has shown to reduce effects over bacterial biofilms from chronic 
infected animals. On the contrary, chitosan is a biopolymer with a wide range of antimicrobial properties30,31. 
Antimicrobial activity of chitosan was evaluated by flow cytometry and plate counts. Bacterial membrane integ-
rity was analyzed using the SYTO9 dye that can be incorporated into all cells (both alive and dead) and propid-
ium iodide (PI) dye that can only be incorporated into dead cells (Fig. 1A–C). We found that chitosan presented 
a strong antimicrobial activity not only on planktonic cultures (Fig. 1A,B,D), but also on preformed biofilms 
(Fig. 1C,D), in a dose-dependent manner. Chitosan concentration required for bacterial killing inside preformed 
biofilms was from 4 to 16 times higher than for the planktonic cultures of the same isolate (Fig. 1D). In our study, 
chitosan presented important bactericidal activity on CNS isolates from chronic bovine mastitis that was inde-
pendent of the antibiotic resistance pattern.
Effect of cloxacillin and chitosan combination on planktonic cultures and bacterial biofilms 
of CNS isolates from chronic bovine mastitis. Next, we evaluated antimicrobial properties of the 
combined- chitosan and cloxacillin on planktonic cultures and preformed biofilms of CNS isolates. We found 
that chitosan addition to cloxacillin drastically reduced the antibiotic concentration needed for bacteria killing 
in different lifestyles. The combined treatment involved an antibiotic 16- to 64- fold reduction in planktonic 
cultures (Table 3), and 5- to 16- fold in preformed biofilms (Table 3), compared with the antibiotic alone. These 
results demonstrate that chitosan addition to cloxacillin formulation increased the efficacy of the antibiotic effect 
reducing the required concentration.
Chitosan and cloxacillin combination inhibited new bacterial biofilms formation and eradi-
cated preformed biofilms. Biofilm formation represents an important mechanism of virulence in antibi-
otic resistance and tolerance. Agents that may help to prevent biomass formation or eradicate preformed biomass 
could be very useful as a complement of antibiotic therapy. To evaluate this, we seeded a bacterial inoculum on a 
flat polystyrene plate in the presence of different concentrations of cloxacillin alone or combined with 200 µg/mL 
chitosan for 24 h (Fig. 2). As can be seen, chitosan and cloxacillin per se significantly inhibited bacterial biofilm 
formation. However, the combined treatment completely inhibited biofilm formation at low cloxacillin concen-
trations (Fig. 2).
In order to determine the effect of single or combined treatments on mature preformed bacterial biofilms, 
CM-CNS were incubated under different conditions. Biofilm biomass, three-dimensional structure and cell via-
bility were analyzed using crystal violet (CV) assay, plate count and confocal scanning laser microscopy (CSLM). 
Our results show that while the addition of cloxacillin and chitosan alone to preformed biofilms significantly 
reduced biofilm biomass (Fig. 3A,C) and bacterial viability count (Fig. 3B), the combined treatment dramatically 
improved the activity of individual components (Fig. 3A–C). Although cloxacillin reduced preformed biofilm 









CM-CNS1 1 4 256 64
CM-CNS2 2 8 128 16
CM-CNS3 1 4 256 64
CM-CNS4 2 4 128 32
CM-CNS5 1 8 256 32
CM-CNS6 2 4 256 64
CM-CNS7 0.250 4 512 128
Table 2. Cloxacillin susceptibility from planktonic cultures and preformed biofilms of CNS isolates from 
chronic bovine mastitis. Cloxacillin Minimal Inhibitory Concentration (MIC). Cloxacillin CLSI-breakpoint 
for CNS were considered ≥0.5 µg/mL. Cloxacillin Minimal Bactericidal Concentration on planktonic cultures 
(P-MBC), Cloxacillin Minimal Bactericidal Concentration on preformed biofilms (B-MBC). Bactericidal ratio 
between preformed biofilms and planktonic cultures (B-MBC/P-MBC).
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concentration required (Fig. 3). Interestingly, the three-dimensional biofilm structure and the bacterial viability 
by CLSM demonstrated that only chitosan addition was able to reduce the thickness and compaction of the bio-
mass structure and induced a slight reduction of bacterial viability, compared with the control condition (Fig. 3C 
and Supplementary Fig. 2). Together, the combined treatment could not only help to prevent the development of 
new foci of bacterial colonization, but also to eradicate preformed biofilms and induce bacterial killing.
Chitosan and cloxacillin combination may improve bacterial clearance of CNS infected mam-
mary epithelial cells. In this work, we also evaluated the antimicrobial effect of chitosan, cloxacillin and 
their combinations on the infection of bovine mammary epithelial cells (MAC-T). CM-CNS isolates used for 
MAC-T infection were selected based on biofilm biomass production. The viability of extracellular and intra-
cellular bacteria was assessed after 24 h of treatment by plate count (Fig. 4A,B). Although chitosan and cloxacil-
lin addition reduced bacterial viability in culture supernatants, the combined treatment significantly decreased 
Figure 1. Antimicrobial activity of chitosan against CNS isolated from chronic intramammary infections. 
CNS growth in planktonic and biofilms forms were treated with different concentration of chitosan. (A) 
Bacterial viability of planktonic cultures were analyzed by flow cytometry using SYTO9 and PI dyes. (B) Bar 
graph shows chitosan effect on planktonic growth of CM-CNS isolates by flow cytometry. (C) Bar graph shows 
chitosan effect on preformed biofilms of CM-CNS isolates by flow cytometry. (D) Data table represents MBC 
in planktonic and biofilms growth by plate count assay. These experiments were performed three independent 
times with three biological replicates and the data are represented by nine independent replicates. Data are 
shown as mean ± SEM. The p values were obtained using two-way ANOVA followed by Bonferroni post-hoc 
analysis. P values *< 0.05, **< 0.01 and ***< 0.001 were considered significant.
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the antibiotic concentration needed to perform extracellular and intracellular bacterial clearance (Fig. 4A,B). 
Cloxacillin addition to infected MAC-T cell cultures reduced the bacterial burden in the extracellular environ-
ment (in a dose-dependent manner), but the antibiotic effectively controlled intracellular infection on MAC-T 
cells only at the high concentrations (Fig. 4A,B). Differences in cloxacillin concentrations required to kill intra 
and extracellular bacteria suggest that intracellular survival might represent an important virulence mecha-
nism associated to chronic infections. Interestingly, although single cloxacillin and chitosan per se addition may 
reduce bacterial viability, combined treatment can significantly diminish the antibiotic concentration needed to 
Planktonic cultures Preformed biofilm
P-MBC [µg/mL] B-MBC [µg/mL]
Clox. Clox. + Ch. Clox/Clox. + Ch. Clox. Clox. + Ch. Clox/Clox. + Ch.
CM-CNS1 4 0.125 32 256 32 8
CM-CNS2 8 0.125 64 128 24 5
CM-CNS3 4 0.125 32 256 48 5
CM-CNS4 4 0.250 16 128 24 5
CM-CNS5 8 0.250 32 256 48 5
CM-CNS6 4 0.125 32 256 32 8
CM-CNS7 4 0.250 16 512 32 16
Table 3. Chitosan addition to cloxacillin treatment reduces antibiotic concentration needed to eliminate CNS 
in planktonic cultures and preformed biofilms. CNS were cultured in the presence of medium or different 
concentrations of cloxacillin [512–0.062 µg/mL] chitosan [200 µg/mL] or cloxacillin and chitosan combined for 
24 h at 37 °C. (A) Planktonic CNS cultures were exposed to different conditions and P-MBC were determined 
in each case. (B) CNS preformed biofilms were exposed to different conditions and B-MBC were determinate 
in each case. Relation between MBC in cloxacillin presence and MBC in cloxacillin and chitosan combined 
presence was determined. These experiments were performed three independent times with three biological 
replicates.
Figure 2. Chitosan prevents CNS bacterial biofilms formation itself and its addition to cloxacillin can help to 
avoid them. Bacterial cultures were seeded in 96-well plates in the presence of medium of different cloxacillin 
[1, 4, 16, 64, 256 µg/mL], chitosan [200 µg/mL] or cloxacillin concentration and chitosan combinations for 
24 h at 37 °C. Biofilm biomass were evaluated by CV and biofilm generated in control condition (medium) 
was considered as 100% of biomass. These experiments were performed three independent times with 
three biological replicates and the data are represented by nine independent replicates. Data are shown as 
mean ± SEM. The p values were obtained using two-way ANOVA followed by Bonferroni post-hoc analysis. P 
values *< 0.05, and **< 0.01 and ***< 0.001 were considered significant.
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perform extracellular and intracellular bacterial clearance (Fig. 4A,B). On the other hand, we observed that chi-
tosan induces a slightly increase in IL-6 and IL-1β proinflammatory cytokines secretion in culture supernatants 
of infected MAC-T cells, while chitosan combined with cloxacillin induces a slightly increase in IL-6 (Fig. 4C). 
We found that the combined therapy could significantly improve the extracellular and intracellular bacterial 
clearance, compared to the single antibiotic treatment. Moreover, based on our findings we could suggest that 
chitosan could not only act as antimicrobial agent against different bacterial lifestyles, but it could also contribute 
to epithelial cell response against CNS.
Finally, the viability of MAC-T cells was evaluated by MTT assay in cultures with medium, cloxacillin [1, 4, 48, 
256 µg/mL], chitosan [100, 200, 400, 800 µg/mL] or different combinations for 48 h. We found that cell viability 
was not affected by any of the conditions tested of cloxacillin, chitosan or their different combinations (Fig. 5). 
Taken together, our data suggest that chitosan added to antibiotic drying therapy could be a safe alternative, 
which could not only improve bacterial clearance in different lifestyles, but also stimulate the defense of infected 
mammary epithelial cells.
Discussion
The lack of development of new antibiotics and the exposure to sub-optimal concentrations could be associ-
ated with a reduced treatment efficacy and resistance development. Designs of new treatments should be gen-
erated through searching for new systems that take into account different forms of growth, avoiding falling into 
the post-antibiotic era, and the effects of not having useful antibiotics to treat resistant bacteria. Bacteria easily 
Figure 3. Chitosan and cloxacillin combination can eradicate preformed biofilms and increase bacterial killing 
inside them. CNS isolates from chronic intramammary infections were grown in 96-well plate for 24 h at 37 °C. 
Preformed biofilms were washed with PBS and incubated in the presence of medium or different concentration 
of cloxacillin [6, 48, 256 µg/mL], chitosan [200 µg/mL] or cloxacillin and chitosan combined for 24 h at 37 °C. 
Biofilm biomass and viable cells were evaluated by CV, plate count and CLSM. (A) Cristal Violet evaluation and 
biofilm generated in control condition (medium) was considered as 100% of biomass. (B) Bacterial Viability was 
evaluated in plate count (CFU/mL). (C) Bacterial viability and biofilm 3D structure were evaluated by staining 
with SYTO9 and PI dyes and analyzed by CLSM microscopy. CLSM images belong to CM-CNS7 isolation 
which was taken as representative. The other isolations showed similar efficiency results. These experiments 
were performed three independent times with two biological replicates and the data are represented by six 
independent replicates. Data are shown as mean ± SEM. P values were obtained using two-way ANOVA 
followed by Bonferroni post-hoc analysis. P values *< 0.05, **< 0.01 and ***< 0.001 were considered 
significant.
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develop different mechanisms and virulence factors that allow adapting to the environment in which they live. 
Unfortunately, the speed at which these adaptations occur poses a great challenge for the pharmaceutical industry 
worldwide that needs to respond more efficiently and faster. In fact, studies in different countries have reported 
higher rates of resistance to antibiotics frequently used to mastitis control8,9,35,36. Empirical practice and uncon-
trolled use may be relevant risk factors for chronic or recurrent infections due to multiresistant and host-adapted 
selection strains33.
Figure 4. Chitosan and cloxacillin combination can reduce extracellular and intracellular MAC-T infection. 
MAC-T cells were infected for 2 h with CNS in a MOI 10. After that, MAC-T cells were cultured in the presence 
of medium or different concentrations of cloxacillin [0.5, 4, 16, 64 µg/mL], chitosan [200 µg/mL] or cloxacillin 
and chitosan combined for 24 h. (A) Graphs bar represent bacteria viability in extracellular supernatants (CFU/
mL). (B) Graphs bar represent bacteria viability in intracellular MAC-T (CFU/mL). (C) Cytokines measured in 
culture supernatants of MAC-T cells treated with different conditions analyzed by ELISA. These experiments 
were performed two independent times with three biological replicates and the data are represented by six 
independent replicates. Data are shown as mean ± SEM. The p values were obtained using one-way ANOVA 
followed by Bonferroni post-hoc analysis. P values *< 0.05, **< 0.01 and ***< 0.001 were considered 
significant.
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In recent years CNS have begun to represent pathogens with the highest antibiotic resistance not only in 
animals but also in human infections37. Reports on the growing importance of CNS as mastitis pathogens have 
increased in Argentina and throughout the world38–40. CNS have been described in persistent, incurable and 
chronic infections intimately associated with tissue damage, decreased milk quality and a higher rate of antibiotic 
multi-resistance compared to other pathogens associated with mastitis5,7,19,20,41,42. Noteworthily, the methicillin 
resistance observed in our study was similar to data observed in bovine mastitis isolates43,44, but higher than other 
reports8,11,12,22. Furthermore, we found that chronic isolates presented a significantly higher macrolide and lin-
cosamide resistance than others reports8,11,22,43. The cumulative evidence obtained in recent years showed signif-
icant problems associated with the chronic use of antibiotics in production animals worldwide. In the last years, 
reports show high methicillin-resistance in CNS isolated from beef meat, poultry farm and chickens45,46. These 
findings highlight the potential risk posed by the consumption of food contaminated with microorganisms with 
this characteristic and the high impact they can have on public health.
Virulence factors associated with the growth of bacteria may be important in the clinical failure of differ-
ent treatments20,47,48. Indeed, recurrent failure of antibiotic therapies has been associated with bacterial isolation 
without antibiotic-resistance genes, suggesting that virulence factors such as different bacterial growths, might 
play a key role in their survival20,22,47,49. In fact, bacterial growth in biofilms or intracellular forms may induce a 
complex mechanism of recalcitrance towards antibiotics, which is associated with different mechanisms of anti-
biotic resistance20,47.
More than 85% of CNS isolated from bovine mastitis can grow in the biofilm form18, and in Argentinean dairy 
cattle this ability is present in more than 97% of isolates22,40. All the CNS isolated from chronic bovine mastitis 
studied here presented strong ability to grow in biofilm form. In our work, we found that planktonic cultures 
needed a significantly lower cloxacillin concentration than the same bacteria that were growing in biofilm form. 
In agreement with our data, other authors have shown that CNS planktonic cells from bovine mastitis with strong 
and weak biofilm phenotype have the same pattern of antibiotic susceptibility, but when grown in biofilm form, 
a significantly higher resistance was detected19,42,50. Interestingly, a strong association between the persistence of 
CNS intramammary infections, in vitro biofilms strength and antimicrobial resistance has been proposed18,19,42,49. 
It seems that properties of bacterial biofilm lifestyle is clearly different from free-living bacterial cells, but inter-
estingly, bacteria from biofilms exhibit emergent properties that are not predictable from planktonic bacteria 
studies47,50. However, the biofilm mode of growth, its relationship to antibiotic resistance, and how it affects such 
resistance have not been fully elucidated51.
Some studies have compared planktonic MIC to minimum biofilm eradication concentrations (MBEC) or 
biofilm minimal inhibitory concentration (BMIC)19,50. Still, the impact of antibiotic treatment over bacterial bio-
film viability deserves further research52. In our work, we compared cloxacillin bactericidal concentration on CNS 
from chronic bovine mastitis isolates in planktonic, biofilm and intracellular lifestyle. The presence of biofilms led 
to a 16- to 128-fold cloxacillin MBC increase, compared to planktonic cells, while intracellular infection produced 
a 4- to 32-fold cloxacillin MBC increase, compared to planktonic cells. Remarkably, antibiotics for the routine 
treatment of staphylococcal infections are generally evaluated to eliminate planktonic cells, while biofilm and 
intracellular bacterial growth are not being considered20,47.
Figure 5. Cloxacillin, chitosan or their different combinations not affect MAC-T viability. MAC-T cells 
were cultured in the presence of medium or different concentrations of chitosan [100, 200, 400, 800 µg/mL], 
cloxacillin [1, 4, 48, 256 µg/mL] or cloxacillin [1, 4, 48, 256 µg/mL] and chitosan [200 µg/mL] combined for 
48 h. Cell viability was assessed by the MTT assay. Graph bars represent MAC-T cells viability in the presence 
of different conditions. These experiments were performed three independent times with three biological 
replicates and the data are represented by nine independent replicates. Data are shown as mean ± SEM. The p 
values were obtained using one-way ANOVA followed by Bonferroni post-hoc analysis. P values ***< 0.001 
were considered significant.
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Current efforts are directed toward finding broad spectrum antimicrobial compounds mainly associated to 
the treatment of bacteria, which could be useful to control and prevent the development and spread of infec-
tions. Chitosan shows antibacterial, antifungal, mucoadhesive and biodegradability properties, while it has been 
reported that this polymer increments intracellular trafficking and tissue regeneration without toxic effects on 
living tissues30,31. Different chitosan formulations have shown important antibiofilms properties against a wide 
range of pathogens53–55. Our data shows that chitosan and cloxacillin combination was more effective on different 
growth mode than their single counterparts were, reducing cloxacillin concentration required to bacteria kill-
ing. Notably, these combinations demonstrated a highly effective action capable of inhibiting biofilm formation 
and eradicating preformed bacterial biofilms, compared to their single counterparts. In agreement with these 
findings, some reports carried out on different bacterial genera, demonstrated that chitosan combined with anti-
biotics presents an important antibacterial activity to planktonic and biofilm bacterial lifestyle56–58. In fact, it has 
been reported that very low molecular weight chitosan and tilmicosin combined not only had synergic effect 
against planktonic and preformed biofilms of S. aureus, but also could reduce bacterial burden in intramammary 
infection in a murine model58. Accordingly, in a model of urinary tract infection the combination of chitosan and 
ciprofloxacin was able to eradicate more efficiently the infection and prevent recurrent episodes of bacteriuria 
caused by uropathogenic Escherichia coli59. This study also showed that animals treated with chitosan formula-
tions, presented greater restoration of the genital tract epithelium integrity59. Recently, it has been reported that 
intramammary applications of chitosan hydrogels during the drying period, produced an improvement in the 
involution of the mammary gland and a stimulation of the innate immunity after calving60.
In summary, our results demonstrate that chitosan and cloxacillin combination reduced the antibiotic con-
centration required for bacterial killing in planktonic cultures, preformed biofilms and infected bovine mammary 
epithelial cells. Furthermore, chitosan incorporation not only improved intramammary bacterial clearance, but 
also led to a slight pro-inflammatory cytokine secretion after infection. To provide optimal protection against 
pathogens, the mammary gland immune system needs to be activated. Specifically, IL-6 is the third master proin-
flammatory cytokine and one of the key mediators of the “acute-phase response” in inflammation61. Production 
of these in vivo cytokines could be very useful to increase the recruitment and activation of immune cells. The 
chronologically coordinated induction of their synthesis at the site of inflammation is crucial for an effective 
inflammatory response, including pathogen clearance, wound healing, and return to the normal state61.
These data suggest that the addition of chitosan to antibiotic therapy could significantly improve the prognosis 
of chronic and persistent intramammary infections. Further studies in clinical trials on chronic infections carried 
out during the drying period should be conducted to validate in vitro results. Our findings could be a promising 
green and safe alternative for the complete cure of remaining infections during the drying period, as well as for 
the prevention of new infection development during the peripartum period.
Materials and Methods
Bacterial isolates, growth conditions and reagents. We use a collection of 209 Staphylococcus spp. 
isolates obtained from 10 independent dairy farms located within a 65 km radius of Villa María city (a major dairy 
producing area of Argentina). Animals with intramammary infections were followed for a 6 to 8-month period. 
Each chronic isolation was obtained after three independent identifications, carried out every 15 days, which rep-
resented a clinical intramammary infection for more than 45 days. Only seven isolates, obtained from four dairy 
farms, could be classified as chronic and were used in this study. These experiments were performed under the 
supervision and approval of the Institutional Ethics Committee for experiments with animals of the Universidad 
Nacional de Villa María. All assays were conducted in accordance with international guidelines and regulations 
for the use and handling of pathogenic microorganisms.
Species identification were previously confirmed by biochemical tests, MALDI-TOFF assay and 16 S sequenc-
ing test40. All chronic isolates were identified as CNS. The isolates were called chronic mastitis (CM)- CNS 
CM-CNS1, CM-CNS2, CM-CNS3, CM-CNS4, CM-CNS5, CM-CNS6 and CM-CNS7. Staphylococcus aureus (S. 
aureus) ATCC 29213, ATCC 25923 and Methicillin-Resistant S. aureus (MRSA) ATCC 43300, S. epidermidis 
ATCC 12228 and ATCC 35984 were used as standard control of assays in each case. The bacterial isolates and 
reference strains were stored at −80 °C, in a nutrient broth containing 20% of glycerol. Inoculum was prepared in 
Trypcase Soy Broth (TSB) at 37 °C 18 to 24 h prior to assay. The inoculums were adjusted using DensiCHEK Plus 
(BioMérieux Inc, Marcy l’Etoile, France) according to McFarland scale values and corroborated by plate counting.
Low molecular weight chitosan 50–90 kDa powder with ≥85% of deacetylation, cloxacillin antibiotic powder, 
Triton X-100, Crystal violet (CV) and 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) 
were purchased to Sigma-Aldrich (Sigma-Aldrich, St. Louis, MO, USA). All the antibiotics disks, nutrient agar 
and nutrient broth were purchased from Britania (CABA, BA, Argentina).
Susceptibility Testing. Antimicrobial susceptibility was determined by the standard disk diffusion method 
according to the Clinical and Laboratory Standards Institute (CLSI) guidelines34. All the bacterial strains were 
recovered on a fresh nutrient TSA 18–24 h prior to antimicrobial test. The direct colony suspension method was 
used to prepare bacterial suspension of 0.5 McFarland turbidity (CLSI). Bacterial suspensions were swabbed uni-
formly across a Müller-Hinton agar plate and antibiotic disks were placed on the surface of the agar. The antibiotic 
disks were placed on the agar surface and the lecture of diameters of inhibitions were collected 18 h after. Results 
were interpreted as either sensitive or resistant according to the inhibitory zone diameters around the disks using 
CLSI breakpoints34. Antibiotic disks assayed to antimicrobial tests included: penicillin (PEN), ampicillin (AMP), 
cefoxitin (FOX), erythromycin (ERY), rifampicin (RIF) and lincomycin (LIN). Cefoxitin disk was used as an indi-
cator of methicillin susceptibility. All antimicrobial agents were chosen with regard to their relevance in mastitis 
therapy. S. aureus ATCC 25923 and S. aureus MRSA were used as quality control of microbiological assays.
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MIC and MBC assay. Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration 
(P-MBC) of components against planktonic bacteria was preformed using microdilution assay according to 
CLSI guidelines34. Briefly, bacterial suspensions containing 5 × 105 CFU/mL were cultured for 24 h at 37 °C into 
96-wells bottom-plate (Deltalab, Barcelona, Spain) in presence of the different concentrations of cloxacillin, chi-
tosan or combinations of them. MIC and MBC were performed in the Muller-Hinton Broth (MHB) at an initial 
concentration of 512 µg/mL of cloxacillin and 3200 µg/mL of chitosan, and then serially diluted. To determine 
P-MBC, each wells with equal and greater MIC in each case was seeded in TS-Agar (TSA) for plate count. Viable 
bacteria were evaluated 24 h after seeded.
Flow cytometry viability assay. Bacterial suspensions were grown in the presence of TSB medium 
(Control) or in different concentrations of chitosan [800, 400, 200, 100, 50 µg/mL] for 24 h at 37 °C. Viability eval-
uation was performed using the LIVE/DEAD BacLight Bacterial Viability Kit staining (Invitrogen, ThermoFisher 
Scientific, CA, USA), according to the manufacturer’s instructions. Bacterial viability is carried out by SYTO9 and 
propidium iodide (PI) dyes which determine cell membrane integrity. SYTO9 dye can be incorporated to live and 
dead bacterial cells and can be useful to determine the total cells population, while PI dye is commonly used for 
identifying dead cells which present disrupted membranes. When both dyes are present, PI increase the intensity 
collected in FL3 filter and generates a bleaching effect of SYTO9 fluorescence intensity. Bacterial suspensions were 
acquired on an ACCURI C6 (BD Biosciences, San Diego, CA, USA) flow cytometer and the data were analyzed 
using FlowJo software (Tree Star, OR, USA).
Biofilm inhibition assay. One hundred microlitres of 1 × 107 CFU/mL of bacterial suspension were cul-
tured in the presence of TSB medium (Control), chitosan [200 µg/mL], cloxacillin [512, 256, 128, 64, 32, 16, 8, 
1 µg/mL] or combinations of chitosan with different concentrations of cloxacillin in 200 uL of final volume for 
24 h at 37 °C. After that, bacterial supernatants were discarded and each individual wells were washed twice with 
sterile PBS and staining with a CV [0.5% w/v]. Excess colorant was washed and dried for 24 h. Colorant bound 
to each well was resuspended with 200 µL of 96% alcohol per well. After 20 min of incubation at room tempera-
ture, 100 µL of each well was transferred to a new 96-well plate and the absorbance of the eluate was measured at 
590 nm using microplate spectrophotometer reader Multiskan GO (ThermoFisher Scientific).
Bactericidal activity and biomass evaluation on preformed biofilms. One hundred microlitres of 
1 × 107 CFU/mL of bacterial suspension in TSB were added to individual wells of flat polystyrene microtitre 
plates. The final volume of 200 µL was completed with TSB medium. Plates were statically incubated for 24 h 
at 37 °C to allow cell bonding and biofilm formation. Supernatants were then discarded and the biofilms were 
washed twice with sterile PBS to remove non-adherent bacteria. The preformed biofilms were treated with differ-
ent concentrations of cloxacillin, chitosan and its respective mixture for 24 h at 37 °C. After that, the biofilm mass 
was evaluated by CV staining. Bacterial viability cultured within biomass of biofilms (B-MBC) were evaluated by 
plate count, after desegregating with 0.1% of Triton X-100 before serial dilution56.
Confocal scanning laser microscopy (CSLM). Biofilms were grown overnight in TSB in flat 8-chamber 
plate Nunc Lab-TekTM Chamber Slides (ThermoFisher Scientific) for 24 h at 37 °C. After that, the medium was 
removed, and the biofilms were washed twice with sterile PBS to remove non-adherent cells. Bacterial inside bio-
films were stained with LIVE/DEAD BacLight Bacterial Viability Kit staining, according to the manufacturer´s 
instructions. Briefly, biofilms were incubated 15 min in dark, after that these were washed twice with sterile PBS 
to remove the excess colorants. The controls biofilms were approximately 30 to 50 µm thick, and Z-slices were 
obtained every 0.5 microns. All confocal images and stacks of images were obtained at the Microscopy Center of 
Universidad Nacional de Córdoba. Each individual chamber was analyzed in a confocal laser scanning micro-
scope (CLSM) Leica DM6000 CS (Leica Microsystems, Wetzlar, Germany), using a 60x oil immersion upright 
objective. The images and stacks of images were analyzed using the FIJI-IMAGEJ analysis software.
Intracellular and planktonic bacteria in MAC-T cells co-cultures. MAC-T cell line from bovine 
mammary alveolar cells were maintained in a DMEM GlutaMAX™ medium (Thermo Fisher Scientific) supple-
mented with 1 μg/mL hydrocortisone (Fada Pharma, CABA, BA, Argentina), 5 μg/mL bovine insulin (Betasint, 
CABA, BA, Argentina), and 10% heat inactivated fetal bovine serum (FBS) (Thermo Fisher Scientific). Cells were 
seeded at 2 × 105 cells/well in 24-well plates and maintained at 37 °C in a water-saturated 5% CO2 atmosphere. 
After that, cells were infected with a fresh bacterial inoculum in a multiplicity of infection (MOI) of 10. Two hours 
after the invasion, cells were washed with medium, prior to addition of cloxacillin, chitosan or different combi-
nation of them, to the culture for 24 h. Extracellular and intracellular bacterial viability were evaluated by plate 
count. Briefly, extracellular bacterial viability was determined by seeding the culture supernatant homogenized in 
TSA plates. After that, MAC-T cells were washed twice with PBS solution and incubated for 2 h with 100 µg/mL 
of gentamicin to eliminate extracellular bacteria. Intracellular bacterial viability was assayed after MAC-T cells 
lysed with 0.1% of Triton x100 and release the intracellular bacteria. Plates were incubated for 24 h at 37 °C and 
the viable bacteria were counted.
Cytokine quantification. Cytokine secretion in culture supernatants of infected MAC-T cells in the pres-
ence of different conditions was assessed. IL-6 and IL-1β concentrations in culture supernatants were measured 
by specific anti-bovine ELISA kit (Thermo Fisher Scientific) following the manufacturer’s instructions.
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Mammalian cytotoxicity assay. MAC-T cells were cultured in the presence of medium or in the presence 
of cloxacillin, chitosan or their combinations, the cytotoxicity effects over them were measured using MTT assay. 
In all cytotoxicity assays, 10% of Triton X-100 has been used as positive control.
Experimental design and statistical analysis. In order to control the strain variability, a two facto-
rial design was developed. A factor was treatment and a second factor was strain. In each “treatment-strain” 
combination, the number of independent replicates used has been specified. Statistical analysis was performed 
using one and two-way ANOVA with Bonferroni post hoc test analysis. Mean ± SEM are represented in the 
graphs. Statistical tests and graphs were performed using the R soft (R Core Team, 2016) and GraphPad Prism 
5.0 (GraphPad Software, Inc., CA, USA). P values *< 0.05, **< 0.01 and ***< 0.001 were considered significant 
in all analyses.
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